Profile data is unavailable for this security.
About the company
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.
- Revenue in USD (TTM)14.37m
- Net income in USD-1.48m
- Incorporated2013
- Employees47.00
- LocationCV Sciences Inc9530 PADGETT STREET, SUITE 107SAN DIEGO 92126United StatesUSA
- Fax+1 (619) 876-4321
- Websitehttps://cvsciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nutraproducts Inc | 0.00 | -821.94k | 7.85m | 0.00 | -- | 1.31 | -- | -- | -1.31 | -1.31 | 0.00 | 0.2973 | 0.00 | -- | -- | -- | -513.70 | -1,177.23 | -740.45 | -- | -- | -- | -- | -- | -- | -385.17 | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 8.00m | -- | 0.0445 | 0.0097 | 2.20 | 0.7511 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| cbdMD Inc | 19.09m | -3.71m | 8.06m | 42.00 | -- | 0.8588 | -- | 0.4222 | -2.23 | -2.23 | 3.11 | 0.8945 | 1.64 | 2.95 | 15.97 | -- | -20.06 | -48.27 | -41.11 | -54.99 | 60.59 | 63.95 | -12.25 | -85.60 | 1.87 | -- | 0.00 | -- | -1.50 | -14.45 | 43.21 | -- | -32.56 | -- |
| Gelteq Ltd | 117.16k | -4.70m | 8.46m | 7.00 | -- | 0.757 | -- | 72.22 | -0.498 | -0.498 | 0.0124 | 1.04 | 0.0078 | -- | 0.5155 | 16,737.72 | -31.47 | -17.38 | -40.60 | -19.16 | -- | -- | -4,011.74 | -4,507.46 | -- | -3.52 | 0.2106 | -- | -- | -- | -87.40 | -- | -- | -- |
| Nexgel Inc | 11.67m | -2.88m | 8.47m | 19.00 | -- | 1.63 | -- | 0.726 | -0.3796 | -0.3796 | 1.53 | 0.6369 | 1.05 | 3.79 | 13.46 | 613,947.40 | -25.14 | -39.08 | -36.83 | -49.79 | 38.30 | 19.60 | -23.91 | -105.40 | 1.08 | -51.36 | 0.1439 | -- | 112.47 | 64.69 | -3.93 | -- | -- | -- |
| Cuprina Holdings (Cayman) Ltd | 23.79k | -2.22m | 8.59m | 14.00 | -- | 1.43 | -- | 361.22 | -0.1222 | -0.1222 | 0.0013 | 0.2806 | 0.0049 | 13.39 | 0.7976 | 1,699.16 | -44.56 | -- | -131.50 | -- | -69.27 | -- | -9,194.46 | -- | 3.58 | -306.25 | 0.0244 | -- | -52.05 | -- | -39.39 | -- | -- | -- |
| Integrated Biopharma Inc | 52.09m | -206.00k | 9.32m | 153.00 | -- | 0.4717 | 81.79 | 0.179 | -0.007 | -0.007 | 1.67 | 0.6365 | 2.12 | 4.94 | 13.32 | 340,464.10 | -0.8373 | 9.98 | -1.03 | 13.68 | 7.81 | 10.74 | -0.3955 | 4.58 | 2.67 | -- | 0.0069 | -- | 8.02 | 0.5933 | 482.30 | -30.67 | -0.8556 | -- |
| Bon Natural Life Ltd | 18.67m | -1.99m | 9.93m | 96.00 | 18.29 | 0.2274 | -- | 0.5319 | 0.088 | 0.088 | 6.74 | 7.08 | 0.2541 | 6.07 | 1.64 | 194,486.40 | -2.79 | 5.82 | -3.97 | 7.86 | 20.77 | 28.53 | -10.98 | 10.83 | 1.61 | -4.44 | 0.1735 | 0.00 | -21.70 | 0.4899 | -577.58 | -- | 18.20 | -- |
| Biofrontera Inc | 37.17m | -17.57m | 10.44m | 92.00 | -- | -- | -- | 0.2809 | -1.84 | -1.84 | 4.07 | -0.2216 | 2.19 | 2.44 | 9.45 | 403,967.40 | -103.57 | -48.03 | -339.69 | -77.55 | 64.41 | 48.93 | -47.28 | -60.99 | 0.8033 | -47.48 | 2.37 | -- | 9.54 | 7.35 | 11.78 | -- | -35.51 | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 10.74m | 233.00 | 0.0734 | 0.0011 | 2.78 | 0.1518 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -15.77m | 11.45m | 8.00 | -- | -- | -- | -- | -0.600 | -0.600 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -65.57 | -112.46 | -136.47 | -257.78 | -- | -- | -- | -- | -- | -27.77 | 0.0854 | -- | -- | -- | -97.75 | -- | -- | -- |
| Cellectar Biosciences Inc | 0.00 | -18.85m | 12.30m | 11.00 | -- | 1.24 | -- | -- | -10.78 | -10.78 | 0.00 | 2.94 | 0.00 | -- | -- | 0.00 | -72.62 | -104.57 | -141.24 | -133.43 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -4.23 | -- | 33.54 | -- |
| CV Sciences Inc | 14.37m | -1.48m | 12.70m | 47.00 | -- | 8.25 | -- | 0.8837 | -0.008 | -0.008 | 0.078 | 0.0084 | 1.87 | 1.67 | 34.74 | 305,659.60 | -19.21 | -44.92 | -66.32 | -105.32 | 47.04 | 42.89 | -10.29 | -49.08 | 0.2125 | -2.02 | 0.3829 | -- | -1.87 | -21.80 | -177.18 | -- | -56.43 | -- |
| Hoth Therapeutics Inc | 0.00 | -12.16m | 15.98m | 2.00 | -- | 1.89 | -- | -- | -1.06 | -1.06 | 0.00 | 0.5442 | 0.00 | -- | -- | 0.00 | -138.61 | -129.47 | -154.67 | -144.30 | -- | -- | -- | -- | -- | -493.48 | 0.00 | -- | -- | -- | -4.37 | -- | -- | -- |
| Natural Alternatives International Inc | 135.16m | -12.25m | 17.11m | 293.00 | -- | 0.2552 | -- | 0.1266 | -2.04 | -2.04 | 22.56 | 10.85 | 0.8736 | 4.35 | 7.80 | 461,286.70 | -7.92 | 0.4593 | -9.61 | 0.5479 | 9.06 | 12.75 | -9.06 | 0.4296 | 0.855 | -1.80 | 0.1787 | 0.00 | 14.12 | 1.78 | -88.10 | -- | -4.46 | -- |
| Lexaria Bioscience Corp | 522.00k | -10.79m | 17.65m | 7.00 | -- | 3.21 | -- | 33.80 | -0.5743 | -0.5743 | 0.0272 | 0.221 | 0.0659 | -- | 2.97 | 74,571.43 | -136.35 | -102.60 | -145.39 | -105.78 | 100.00 | 87.95 | -2,069.41 | -1,579.38 | -- | -285.30 | 0.00 | -- | 52.05 | 17.53 | -105.37 | -- | 48.50 | -- |
Data as of Mar 05 2026. Currency figures normalised to CV Sciences Inc's reporting currency: US Dollar USD
